Home › Juvenile Arthritis
Juvenile Arthritis clinical trials recruiting in the U.S.
16 studies for Juvenile Arthritis are recruiting participants at sites across the United States.
Juvenile arthritis or JA, causes joint swelling, pain, stiffness and loss of motion in children. Learn diagnosis and tests for JA.
Cities with the most studies
- Washington, DC6 studies
- Cincinnati, OH5 studies
- Portland, OR5 studies
- New York City, NY4 studies
- Pittsburgh, PA4 studies
- Salt Lake City, UT4 studies
- Cleveland, OH3 studies
- Gainesville, FL3 studies
- Indianapolis, IN3 studies
By state
- California3 studies
- District of Columbia4 studies
- Florida4 studies
- Indiana3 studies
- New York5 studies
- North Carolina3 studies
- Ohio7 studies
- Oregon5 studies
- Pennsylvania4 studies
- Texas4 studies
- Utah4 studies
Recently updated studies
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
RecruitingPhase 1
Ages 2 to 17 · All sexes · Updated Sep 28, 2026 · NCT06751238Natural History and Development of Spondyloarthritis
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 99 · All sexes · Updated Sep 28, 2026 · NCT01422694A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Sep 25, 2026 · NCT06663332A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
RecruitingPhase 2
Ages 1 and older · All sexes · Updated Sep 25, 2026 · NCT07203001Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
RecruitingPhase 3
Ages 2 to 21 · All sexes · Updated Sep 25, 2026 · NCT06654882Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
RecruitingPhase 3
Ages 1 to 17 · All sexes · Updated Sep 15, 2026 · NCT05609630Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 10, 2026 · NCT06339177A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
RecruitingObservational study
Ages 5 to 21 · All sexes · Updated Jul 24, 2026 · NCT04833465Pain in Juvenile Arthritis
RecruitingHealthy volunteers welcome
Ages 9 to 17 · All sexes · Updated Jul 14, 2026 · NCT07217782Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07138898The BRIDGE Pain Study
RecruitingObservational study
Ages 14 to 26 · All sexes · Updated May 22, 2026 · NCT07602595Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Jan 22, 2026 · NCT04806620Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
RecruitingPhase 2
2 Months – 55 Years · All sexes · Updated Dec 15, 2025 · NCT01962415Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
RecruitingObservational studyHealthy volunteers welcome
Ages 5 to 85 · All sexes · Updated Jul 17, 2025 · NCT07065747From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.